Schedule 13D ownership disclosure

TALIS BIOMEDICAL CORP

Security class unavailable · CUSIP: 87424L207

Event date: 2024-10-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,506,716
Percent of class
65.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-107750
Form type
SC 13D/A
Filer
BAKER BROS. ADVISORS LP
CIK
CIK 1263508
Filed
Oct 10, 2024
Reporting period
Oct 08, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub